More than 11,000 bottles of a commonly prescribed blood pressure medication have been recalled across the United States after a manufacturing issue raised concerns about how the tablets dissolve in the body.
Inventia Healthcare Limited initiated a voluntary recall of Chlorthalidone Tablets USP, 25 mg, on June 5, according to federal records.
The recall affects both 100-count and 1,000-count bottles distributed nationwide by Rising Pharma Holdings Inc., a New Jersey-based pharmaceutical company.
According to the US Food and Drug Administration’s enforcement report, the recalled medication failed dissolution specifications, meaning the tablets may not dissolve as intended after being taken.
Chlorthalidone is commonly prescribed to treat high blood pressure and fluid retention.
The recall includes:
- 100-count bottles, lot number RISA24001, expiration date April 2027
- 1,000-count bottles, lot number RISB24002, expiration date April 2027
A total of 11,460 bottles are included in the recall.
Patients who take Chlorthalidone should check their prescription bottles and consult a pharmacist or healthcare provider if they believe they may have received medication from an affected lot.
Health experts generally advise patients not to stop taking prescribed medications without first speaking with a healthcare professional, as abruptly discontinuing treatment could create additional health risks.
Don’t Miss: NYC Mayor Zohran Mamdani Says He Uses Minoxidil To Keep Hair Loss At Bay. Here Are Possible Side Effects
